{"id":"W2949134677","doi":"10.1097/01.hs9.0000562560.17744.f0","title":"PS1066 AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN REFRACTORY LARGE B CELL LYMPHOMA: OUTCOMES IN PATIENTS ≥ OR < 65 YEARS OF AGE IN THE PIVOTAL PHASE 1/2 ZUMA‐1 STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Refractory (planetary science); Leukapheresis; Lymphoma; Adverse effect; Gastroenterology; Phases of clinical research; Clinical endpoint; Oncology; Surgery; Chemotherapy; Clinical trial; Stem cell; CD34","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008942866,0.0003976617,0.000593177,0.0002113057,0.0001574348,0.0005074121,0.0001948001,0.0003015622,0.001167732],"category_scores_gemma":[0.0003685126,0.0001220868,0.0005803613,0.000276618,0.0002272664,0.0003267014,0.0001956866,0.0006384247,0.000253337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004649145,"about_ca_system_score_gemma":0.0004970244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005103693,"about_ca_topic_score_gemma":0.001628228,"domain_scores_codex":[0.9998121,0.00008204416,0.00001003566,0.00002526778,0.00002742794,0.00004328036],"domain_scores_gemma":[0.9997731,0.00003036802,0.00006669368,0.00001047957,0.00001239917,0.0001069071],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5450056,0.01601698,0.133221,0.001202674,0.002641337,0.0007578623,0.0003770097,0.00488977,0.04850304,0.0005173082,0.009992136,0.2368753],"study_design_scores_gemma":[0.2459581,0.3821181,0.3447165,0.0001853349,0.002533955,0.001305609,0.0002215032,0.003228678,0.007128753,0.0004520593,0.01210061,0.00005086996],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955901,0.002642841,0.00009874521,0.0001499484,0.0000290494,0.0001249791,0.0003184587,0.00001364642,0.001032308],"genre_scores_gemma":[0.9965681,0.00122381,0.0001785943,0.0002704072,0.00005387783,0.0001375092,0.0009097205,0.000004604977,0.0006532471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001167732,"threshold_uncertainty_score":0.004729509,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01893548555659678,"score_gpt":0.3133359228833495,"score_spread":0.2944004373267528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}